Top Markets
Coin of the day
AIxCrypto Holdings, Inc. AIxCrypto Holdings, Inc.

AIxCrypto Holdings, Inc.

AIXC
Rangering i aksjer #27452
AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company... AIxCrypto Holdings, Inc. is a clinical-stage biopharmaceutical company committed to discovering and developing innovative treatments for both adult and pediatric oncology. Its leading investigational therapeutic, QN-302, is a small molecule G-quadruplexes (G4)-selective transcription inhibitor currently progressing through Phase I clinical trials for pancreatic cancer and a range of other solid tumors. The firm is also advancing Pan-RAS, a preclinical-stage program targeting advanced solid tumors. Founded in 1996 and headquartered in Carlsbad, California, the company rebranded from Qualigen Therapeutics, Inc. to AIxCrypto Holdings, Inc. in November 2025.
Aksjekurs
$1.62
Sist synkronisert: 2026-08-19
Markedsverdi
$32.77M
Endring (1 dag)
22.67%
Endring (1 år)
-13.87%
Land
US
Handel AIxCrypto Holdings, Inc. (AIXC)

Kategori

EPS for AIxCrypto Holdings, Inc. (AIXC)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til AIxCrypto Holdings, Inc. er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for AIxCrypto Holdings, Inc. fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter